Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC (R)-pirtobrutinib | 2101700-14-3 | 99.8% | C22H21F4N5O3 | 10MG
SDP

Supplier:  Medchemexpress LLC HY131328A10MG

Encompass_Preferred

(R)-Pirtobrutinib is the R-enantiomer of pirtobrutinib (LOXO-305), a selective, non-covalent Bruton's tyrosine kinase (BTK) inhibitor used for biochemical and cellular research into BTK signaling and resistance mutations, including C481 substitutions. The compound is supplied as a high-purity solid with established solubility and storage profiles for laboratory use.

  • High purity (99.8%).
  • Selective, non-covalent BTK inhibitor active against C481 substitution mutations.
  • Soluble in DMSO (≈200 mg/mL); ultrasonic assistance recommended.
  • Light yellow to yellow solid appearance.
  • Stable under defined storage: powder -20°C (3 years) or 4°C (2 years); in solvent -80°C (6 months) or -20°C (1 month).
  • Intended for research use only.

Catalog No. 50-002-60255


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.